Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.
The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...
This investor's weighing up a couple of world-class companies for his Stocks and Shares ISA after the US election sparked a sell-off.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback